Valeo Financial Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$303K Buy
3,851
+13
+0.3% +$903 0.01% 627
2026
Q2
$242K Sell
3,838
-4
-0.1% -$256 0.01% 697
2026
Q1
$270K Sell
3,842
-73
-2% -$5.1K 0.01% 592
2025
Q4
$321K Buy
3,915
+392
+11% +$29.3K 0.01% 597
2025
Q3
$209K Buy
+3,523
New +$173K ﹤0.01% 740

Other funds holding TARS

Valeo Financial Advisors's TARS Position: Q3 2026 in Review

Valeo Financial Advisors increased its Tarsus Pharmaceuticals (TARS) stake by 0.34% in Q3 2026, buying an estimated $903 and bringing the position to 3,851 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #627.

Valeo Financial Advisors first reported a position in TARS in Q3 2025 and has held it in 5 quarters since. The position peaked at $321K in Q4 2025. 254 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Valeo Financial Advisors held 3,851 shares of Tarsus Pharmaceuticals worth $303K as of Q3 2026.
  • Valeo Financial Advisors bought 13 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $903.
  • Tarsus Pharmaceuticals made up 0.01% of Valeo Financial Advisors's portfolio in Q3 2026, its #627 holding.
  • Valeo Financial Advisors first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Valeo Financial Advisors's Tarsus Pharmaceuticals position peaked at $321K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Valeo Financial Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.